Fentanils and synthetic cannabinoids: driving greater complexity into the drug situation — an update from the EU Early Warning System
In this update from the EU Early Warning System, the EMCDDA aims to provide insights into what is happening with new psychoactive substances in Europe, based on data from the agency’s early warning and risk-assessment activities. This report covers the period from January 2016 until December 2017.
Table of contents
- Overview of seizures, 2016-17
- Synthetic opioids
- Synthetic cannabinoids
- New challenges, new responses
- Discussion and conclusion